Lee Jeong Woo, Cho Sung Yong, Jeon Chanhoo, Ko Kyungtae, Kim Hyeon Hoe
Department of Urology, Sanggye Paik Hospital, Inje University College of Medicine, Dongil-ro, Nowon-gu, Seoul, Republic of Korea;
Department of Urology, SMG-SNU Boramae Medical Center, Dongjak-gu, Seoul, Republic of Korea;
Can Urol Assoc J. 2014 Nov;8(11-12):E810-4. doi: 10.5489/cuaj.1642.
We evaluated the the association between PADUA scores and postoperative renal function (after robot-assisted partial nephrectomy [RAPN]) and between PADUA scores and warm ischemic time (during RAPN).
We reviewed the clinical records of 106 patients who underwent RAPN for a single localized renal tumour between April 2009 and June 2012. Postoperative renal function was evaluated using estimated glomerular filtration rate (eGFR) in 85 patients who were followed for at least 6 months. PADUA scores for renal tumours were calculated using contrast-enhanced computed tomography images, if needed, along with magnetic resonance images in some cases.
A PADUA score ≥10 and WIT ≥30 minutes were observed in 18 (17.0%) and 51 (48.1%) cases, respectively. PADUA scores were significantly correlated with WIT (p = 0.019) and percent change in eGFR at 6 months postoperatively (p = 0.005). PADUA score (continuous variable, odds ratio [OR] 1.694, p = 0.007) and the high-risk group (PADUA score ≥10) (OR 5.429; p = 0.020) were significantly associated with a WIT of ≥30 minutes by multivariate analysis. A 1-point increase in the PADUA score was associated with an eGFR decrease of >20% at 6 months after RAPN (OR 1.799; p = 0.076). In addition, a PADUA score ≥10, or high risk, (OR 13.965; p = 0.003) was an independent predictor of an eGFR decrease of >20% at 6 months after RAPN.
The PADUA classification can reliably predict WIT and postoperative renal functional outcome after RAPN. Furthermore, the study suggests that anatomical aspects of renal tumours are associated with functional outcome after RAPN.
我们评估了PADUA评分与术后肾功能(机器人辅助肾部分切除术[RAPN]后)之间以及PADUA评分与热缺血时间(RAPN期间)之间的关联。
我们回顾了2009年4月至2012年6月期间因单一局限性肾肿瘤接受RAPN的106例患者的临床记录。对85例随访至少6个月的患者,使用估计肾小球滤过率(eGFR)评估术后肾功能。必要时,利用增强计算机断层扫描图像,并在某些情况下结合磁共振图像计算肾肿瘤的PADUA评分。
分别在18例(17.0%)和51例(48.1%)病例中观察到PADUA评分≥10分和热缺血时间≥30分钟。PADUA评分与热缺血时间(p = 0.019)及术后6个月时eGFR的变化百分比(p = 0.005)显著相关。多因素分析显示,PADUA评分(连续变量,比值比[OR] 1.694,p = 0.007)和高危组(PADUA评分≥10分)(OR 5.429;p = 0.020)与热缺血时间≥30分钟显著相关。RAPN术后6个月时,PADUA评分每增加1分,eGFR下降>20%(OR 1.799;p = 0.076)。此外,PADUA评分≥10分或高危(OR 13.965;p = 0.003)是RAPN术后6个月时eGFR下降>20%的独立预测因素。
PADUA分类能够可靠地预测RAPN后的热缺血时间和术后肾功能结局。此外,该研究表明肾肿瘤的解剖学特征与RAPN后的功能结局相关。